Search research articles
Contact Us
Filters
Showing results (321-330 of 334) with videos related to
Page
of 34
Sort By:
Nature
|
November 29, 2013
Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity
John W Schoggins, Donna A MacDuff, Naoko Imanaka, et al.
ACS Central Science
|
September 2, 2024
<i>Epi</i>-Cyclophellitol Cyclosulfate, a Mechanism-Based Endoplasmic Reticulum α-Glucosidase II Inhibitor, Blocks Replication of SARS-CoV-2 and Other Coronaviruses
Melissa Thaler, Tim P Ofman, Ken Kok, et al.
RSC Medicinal Chemistry
|
January 8, 2026
Crystallographic characterisation and development of bi-substrate inhibitors of coronavirus nsp14 methyltransferase
Irene Georgiou, Colin Robinson, Sean N O'Byrne, et al.
NPJ Vaccines
|
October 21, 2020
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
Rinke Bos, Lucy Rutten, Joan E M van der Lubbe, et al.
Molecules (Basel, Switzerland)
|
February 15, 2022
Synthesis, Structure-Activity Relationships, and Antiviral Profiling of 1-Heteroaryl-2-Alkoxyphenyl Analogs as Inhibitors of SARS-CoV-2 Replication
Dorothée Bardiot, Laura Vangeel, Mohamed Koukni, et al.
Respiratory Medicine
|
February 4, 2021
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry
Hossein-Ardeschir Ghofrani, Miguel-Angel Gomez Sanchez, Marc Humbert, et al.
Respiratory Medicine
|
January 10, 2021
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry
Marius M Hoeper, Miguel-Angel Gomez Sanchez, Marc Humbert, et al.
NPJ Vaccines
|
March 20, 2021
Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease
Joan E M van der Lubbe, Sietske K Rosendahl Huber, Aneesh Vijayan, et al.
Antiviral Research
|
December 18, 2007
The VIZIER project: preparedness against pathogenic RNA viruses
B Coutard, A E Gorbalenya, E J Snijder, et al.
The Lancet. Microbe
|
October 5, 2020
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study
Bernadette Schurink, Eva Roos, Teodora Radonic, et al.
Page
of 34
Search research articles
Search
Showing results (321-330 of 334) with videos related to
Sort By:
Page
of 34
Nature
|
November 29, 2013
Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity
John W Schoggins, Donna A MacDuff, Naoko Imanaka, et al.
ACS Central Science
|
September 2, 2024
<i>Epi</i>-Cyclophellitol Cyclosulfate, a Mechanism-Based Endoplasmic Reticulum α-Glucosidase II Inhibitor, Blocks Replication of SARS-CoV-2 and Other Coronaviruses
Melissa Thaler, Tim P Ofman, Ken Kok, et al.
RSC Medicinal Chemistry
|
January 8, 2026
Crystallographic characterisation and development of bi-substrate inhibitors of coronavirus nsp14 methyltransferase
Irene Georgiou, Colin Robinson, Sean N O'Byrne, et al.
NPJ Vaccines
|
October 21, 2020
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
Rinke Bos, Lucy Rutten, Joan E M van der Lubbe, et al.
Molecules (Basel, Switzerland)
|
February 15, 2022
Synthesis, Structure-Activity Relationships, and Antiviral Profiling of 1-Heteroaryl-2-Alkoxyphenyl Analogs as Inhibitors of SARS-CoV-2 Replication
Dorothée Bardiot, Laura Vangeel, Mohamed Koukni, et al.
Respiratory Medicine
|
February 4, 2021
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry
Hossein-Ardeschir Ghofrani, Miguel-Angel Gomez Sanchez, Marc Humbert, et al.
Respiratory Medicine
|
January 10, 2021
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry
Marius M Hoeper, Miguel-Angel Gomez Sanchez, Marc Humbert, et al.
NPJ Vaccines
|
March 20, 2021
Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease
Joan E M van der Lubbe, Sietske K Rosendahl Huber, Aneesh Vijayan, et al.
Antiviral Research
|
December 18, 2007
The VIZIER project: preparedness against pathogenic RNA viruses
B Coutard, A E Gorbalenya, E J Snijder, et al.
The Lancet. Microbe
|
October 5, 2020
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study
Bernadette Schurink, Eva Roos, Teodora Radonic, et al.
Page
of 34